Visualizing Real-World Pain Treatment Pathways in Chronic Disease: A Sequence-Based Analysis of Polypharmacy in Systemic Lupus Erythematosus. [PDF]
Le N +8 more
europepmc +1 more source
Summary The term Equine Gastric Ulcer Syndrome (EGUS) has been used since 1999. As there are important differences, the terms Equine Squamous Gastric Disease (ESGD) and Equine Glandular Gastric Disease (EGGD) were introduced in 2015. Risk factors like dietary management, training regimens and drug side effects, as described for NSAIDs, predispose ...
R. Lensing, A. K. Barton
wiley +1 more source
Association Between Pre-hospital Medication Use and Outcomes in Patients Hospitalized for COVID-19 Pneumonia: A Multicenter Observational Study in the Netherlands. [PDF]
Li L +11 more
europepmc +1 more source
Chronic peptic ulceration and nonsteroidal anti-inflammatory drugs: More to be said about NSAIDs?
Nicholas J. Talley
openalex +1 more source
Field‐applicable low‐intensity exercise induces bronchodilation in horses with severe asthma
Abstract Background Airway dysfunction in severe equine asthma (SEA) often results in early retirement or euthanasia of affected horses. Exercise‐induced bronchodilation occurs in horses with SEA after intense treadmill exercise, but the effects of a lighter, field‐applicable, training regimen remain largely unexplored.
Sophie Mainguy‐Seers +2 more
wiley +1 more source
Pain management after hallux valgus repair surgery: an updated systematic review and procedure-specific postoperative pain management (PROSPECT) recommendations. [PDF]
Wust M +9 more
europepmc +1 more source
Cardiovascular effects and the use of nonsteroidal anti-inflammatory drugs : CPD article
Natalie Schellack
openalex +1 more source
Nonsteroidal antiinflammatory drugs and colorectal cancer
Joshua Muscat +2 more
openalex +1 more source
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow +3 more
wiley +1 more source

